Revel is hiring a Research Associate
The role focuses on lab operations and diseases of aging, seeking a motivated individual to join the team.
See the latest news and media coverage for Revel. We track all announcements, press releases, and industry mentions in real time, all in one place.
Therapeutic enzyme developer targeting age-related damage
revelpharmaceuticals.comLast updated
The role focuses on lab operations and diseases of aging, seeking a motivated individual to join the team.
Revel Pharmaceuticals today announced a study published by its scientists as well as researchers at Calico and the University of Colorado Anschutz Medical Campus, in...
SAN FRANCISCO, March 17, 2022 (GLOBE NEWSWIRE) -- Revel Pharmaceuticals, a longevity therapeutics company developing enzymes to repair damage from aging, announced today that it...
Revel Pharmaceuticals recently announced it has raised $8.4 million in seed financing. The oversubscribed round was led by Kizoo Technology Capital, a...
But an innovative new program is ... Revel Pharmaceuticals, an alumnus of MBC BioLabs in San Carlos. Revel has tapped the Agilent Instrument Subscriptions Program...
Track Revel and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.